Gastrointestinal Features of 22q11.2 Deletion Syndrome Include Chronic Motility Problems From Childhood to Adulthood
- 1 June 2022
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 75 (2) , E8-E14
Abstract
Objectives: 22q11.2 deletion syndrome (22q11.2DS) is the most common chromosomal microdeletion syndrome and has a multisystemic presentation including gastrointestinal features that have not yet been fully described. Our aim was to examine lifetime gastrointestinal problems in a large cohort of patients with 22q11.2DS.Methods: All patients followed in the 22q and You Center at the Children's Hospital of Philadelphia (n = 1421) were retrospectively screened for: 1) age ≥ 17 years, 2) documented chromosomal microdeletion within the 22q11.2 LCR22A‐LCR22D region, and 3) sufficient clinical data to characterize the adult gastrointestinal phenotype. Gastrointestinal problems in childhood, adolescence, and adulthood were summarized. Statistical association testing of symptoms against other patient characteristics was performed.Results: Included patients (n = 206; 46% female; mean age, 27 years; median follow‐up, 21 years) had similar clinical characteristics to the overall cohort. Genetic distribution was also similar, with 96% having deletions including the critical LCR22A‐LCR22B segment (95% in the overall cohort). Most patients experienced chronic gastrointestinal symptoms in their lifetime (91%), but congenital gastrointestinal malformations (3.5%) and gastrointestinal autoimmune diseases (1.5%) were uncommon. Chronic symptoms without anatomic or pathologic abnormalities represented the vast burden of illness. Chronic symptoms in adulthood are associated with other chronic gastrointestinal symptoms and psychiatric comorbidities (P < 0.01) but not with deletion size or physiologic comorbidities (P > 0.05). One exception was increased nausea/vomiting in hypothyroidism (P = 0.002).Conclusions: Functional gastrointestinal disorders (FGIDs) are a common cause of ill health in children and adults with 22q11.2DS. Providers should consider screening for the deletion in patients presenting with FGIDs and associated comorbidities such as neuropsychiatric illness, congenital heart disease, and palatal abnormalities.Keywords
This publication has 46 references indexed in Scilit:
- American Gastroenterological Association Medical Position Statement on ConstipationGastroenterology, 2013
- Celiac DiseaseNew England Journal of Medicine, 2012
- Practical Guidelines for Managing Patients with 22q11.2 Deletion SyndromeThe Journal of Pediatrics, 2011
- Recurrent nausea, vomiting and abdominal pain due to hypothyroidismBMJ Case Reports, 2010
- Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndromeEuropean Journal of Pediatrics, 2010
- Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case-control analysisHeart, 2008
- Childhood Functional Gastrointestinal Disorders: Child/AdolescentGastroenterology, 2006
- The 22q11.2 deletion in African‐American patients: An underdiagnosed population?American Journal of Medical Genetics Part A, 2005
- Thrombocytopenia in patients with chromosome 22q11.2 deletion syndromeThe Journal of Pediatrics, 2003
- Juvenile rheumatoid arthritis‐like polyarthritis in chromosome 22q11.2 deletion syndrome (digeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome)Arthritis & Rheumatism, 1997